The Membership Committee reviews the makeup of the membership and provides the Board with regular updates with respect to numbers, location and corresponding statistics. It recommends to the Board any changes to procedural rules or regulations and reviews membership relations within ISoP including, but not limited to, communications, benefits, controversies, complaints, resignations, and non-payment of dues. It provides advice the Board on strategies for retaining and growing membership.
|
Manuel Ibarra is an Associate Professor of the Pharmaceutical Sciences Department at the School of Chemistry – Universidad de la República (UdelaR) of Uruguay, where he currently is the Analytical and Biostatistics Supervisor of the University’s Bioavailability and Bioequivalence Centre for Medicine Evaluation (CEBIOBE).
He studied Pharmaceutical Chemistry at the School of Chemistry obtaining his Master’s degree in 2009. In 2010 he started the Chemistry Postgraduate program at UdelaR, with focus on the evaluation of sex-related differences in drug pharmacokinetics and bioequivalence. He was awarded with the Ph.D. degree in 2014. During his Ph.D. studies, while doing a short-term scholarship at the College of Pharmacy of the University of Florida (Pharmaceutics Department), he got involved with the science of pharmacometrics. Since then, his research focus has been exploring and developing pharmacometric models in basic and applied pharmacological research, aiming to the understanding of specific pharmacokinetic processes and translational applications such as model-informed precision dosing, virtual & model-based bioequivalence, among other applications. He contributes to the pharmacometric analysis of data generated at CEBIOBE and the Therapeutic Drug Monitoring Unit of the University Hospital and supervises the work of PhD and grade students. Some of his work includes the local and regional active promotion and dissemination of pharmacometrics. He is a co-founder and the Uruguayan Coordinator of the Iberoamerican Pharmacometrics Network (RedIF, redifar.org). In addition, he is a member of the World Conference on Pharmacometrics (WCoP) Executive Committee in representation of Latin America. |
|
Eduardo is a Postdoctoral Research Fellow member of the Division of Clinical Pharmacology at the University of Cape Town, South Africa. He studied Pharmacobiological Chemistry at the University of San Luis Potosi, Mexico, where he obtained his Master and Doctoral degrees in 2016 and 2020, respectively. During his postgraduate studies he worked on population pharmacokinetics and pharmacogenetics of immunosuppressive drugs in kidney transplant patients. In 2021, Eduardo joined the Division of Clinical Pharmacology at the University of Cape Town as postdoctoral research fellow. His research focuses on the development of nonlinear mixed-effects models for multidrug-resistance tuberculosis treatment. |
|
Ana’s career has been mainly working in Industry with small and large molecules focusing on the therapeutic areas of oncology and Inflammation. Ana is a Senior Principal Scientist and Group Leader at Metrum Research Group. In the past, Ana led the Pfizer Oncology Pharmacometrics group and her team was awarded several times for delivering high quality work and closely collaborating with clinical, statistics and translational medicine putting together solid and successful submission packages. Ana has worked on the quantitative aspects of more than 9 successful submissions (including small and large molecules) to different regulatory agencies. Ana holds a Pharm.D, a Masters in Statistics, and a PhD in quantitative Pharmacology. Ana has mentored many junior scientists throughout her career and led different groups. Furthermore, Ana holds a position as Assistant Clinical Professor at Skaggs School of Pharmacy, University of California San Diego (UCSD), she is a member of the ISoP Publication Committee, ISoP Board of directors, and and PAGE scientific Committee. |
|
Nicolas Simon MD PhD, is professor of pharmacology at Aix-Marseille University, school of medicine. He is an addiction specialist and his clinical activity focused on substance use disorders. He is also the head of the poison control center for the Southeast of France. His research in clinical pharmacology are centered on the dose-concentration-effect relationship using a population PK/PD approach and has written more than 140 articles and 2 books on the subject. |
|
Nacho is a pharmacist by training. Nacho received a scholarship from the Spanish Ministry of Education when wrapping up his graduate Pharm.D program, which gave him the opportunity to discover and love the field of pharmacometrics. During Nacho’s Master degree and PhD programs, he learnt new skills independently and quickly; 9 years later he still enjoying this never-ending learning path. Nacho is passionate an enthusiastic at work and enjoys new challenges. He describes himself as a positive thinker that is always looking for a reason to smile. Nacho considers himself a long-life learner due to his curiosity as well as a self-taught person that quickly picks up new skills. Nacho works at Astra Zeneca as Associate Director of Clinical Pharmacology and Pharmacometrics. Nacho is located is Cambridge , UK. |
|
Dr. Ahmed A. Abulfathi is a clinical pharmacologist who trained at Tygerberg Hospital, obtained Master of Medicine & PhD degrees from Stellenbosch University, South Africa, and MBBS degree from University of Maiduguri, Nigeria, where he is currently a lecturer in the Department of Clinical Pharmacology and Therapeutics. Ahmed is a Consultant at Respiratory/Clinical Pharmacology unit, Department of Medicine, University of Maiduguri Teaching Hospital, Maiduguri. Ahmed’s clinical experience spans over a decade, and in the past 7 years, has been involved in various clinical trials conducted in South Africa. Ahmed is passionate about advancing science to improve global health. His research interests include the use of pharmacometrics methods to optimize tuberculosis treatment. Ahmed acquired further research skills as a visiting scholar to Pharmacometrics group, Uppsala University, Sweden and as a Next Generation Scientist, with Novartis Pharma/University of Basel, Switzerland, and is a contract researcher at the Arctic University, Norway. Ahmed is an Examiner of the College of Clinical Pharmacologists of South Africa, Colleges of Medicine of South Africa, a member of the Education Committee of the American College of Clinical Pharmacologists, and PanACEA core Clinical Pharmacology team, and is supported by grant from European and Developing Countries Clinical Trials Partnership (EDCTP) 2 programme supported by the European Union. He has won grants and awards including Chevron/NNPC undergraduate scholarship, PanACEA postgraduate scholarship, HD Brede award for the best postgraduate research in infectious diseases (clinical category), SASBCP best podium award in Clinical Pharmacology, and several travel and publication incentive grants. Ahmed, a former member of Stellenbosch University’s Health Research Ethics Committee-1, contributed to ensuring the ethical conduct of clinical research in South Africa. |
|
Akiyuki works at Pfizer R&D Japan as Senior Manager, Pharmacometrician, of Clinical Pharmacology. He is located in Tokyo, Japan. He has over 25 years working on pharmacometrics in pharmaceurtical industory. He contributes not only to local development, but also global development. He had obtained a Master’s degree in Gifu Pharmaceutical University. After that he joined in Bristrol-Myers Squib KK. In 2001, he joined in Pfizer Japan Inc. He had obtained a PhD in Showa University School of Pharmacy in 2019. He was a part-time teacher (Clinical Pharmacokinetics) in Kitasato University School of Pharmacy from 2009 to 2019. |
|
Naveed Shaik has more than 13 years of oncology drug development experience in the pharmaceutical industry working on small and large molecules in early and late stage drug development. Naveed received his BPharm from Osmania University, India and PhD in Pharmaceutics from University of Minnesota. Naveed has 35 peer-reviewed publications and more than 40 conference presentations. Naveed is located at La Jolla. Additionally, Naveed is as Associate Clinical Professor at the University of California San Diego Skaggs School of Pharmacy, where he has taught workshops and lectures to PharmD students. |
|
Obinna Obianom is a scientist developer at Cognigen. In this role, he takes on projects both in the software development and pharmacometrics departments as both a software engineer and a pharmacometrician, respectively. He graduated with a bachelor’s degree and master’s degree from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. He enrolled in the doctorate program in pharmaceutical sciences at the University of Maryland, Baltimore. During this time, he gained experience both in the design and execution of pharmacology and pharmacokinetics experiments. With several publications in top tier journals through this work, he became an ORISE fellow at the United States Food and Drug Administration (FDA). His work at the FDA focused on population pharmacokinetic modeling and simulations and led to the publication of two articles in top pharmaceutical sciences journals. Since then, with 8+ combined laboratory and regulatory experience, he has joined Cognigen corporation in his current role to aid in both drug development and building of emerging tools for data analysis in drug development. |
Lourdes Eduardo Resendiz
Ana Ruiz
Nacho Gonzalez
Ahmed A. Abulfathi
Akiyuki Suzuki
Naveed Shaik
Obina Obianom